Debt-addicted companies look to equity as interest costs skyrocket
For the first time in a long while, it’s cheaper for some companies in the U.S. to sell shares than to borrow in the debt markets. Read more
Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For the first time in a long while, it’s cheaper for some companies in the U.S. to sell shares than to borrow in the debt markets. Read more
Company Raises 2024 Revenue Guidance and Delivers Positive Adjusted EPS in Q4
On December 31, 2023, Glenview Capital Management, led by Larry Robbins (Trades, Portfolio), made a significant addition to its investment portfolio by acquiring 1,500,000 shares of Myriad Genetics Inc (NASDAQ:MYGN). The trade had a 0.65% impact on the portfolio, bringing the position to 2.29% of the portfolio and 5.97% of the company's shares.
SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The